ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Protocol ID
OPTIMISE
Disease (Sub Disease)
Solid Tumour
CNS Tumour
Lymphoma
Diagnosis Stage
Relapsed/Recurrent
Location
NSW, QLD
Links
External Registry ≫
Trial Status
Open
Study Type
Treatment
Phase
Phase 2
Age Eligibility
0 - 21 years
ANZCTR
NCT06208657
Back to Registry
Study Title Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Protocol ID OPTIMISE
Disease (Sub Disease) Solid Tumour
CNS Tumour
Lymphoma
Diagnosis Stage Relapsed/Recurrent
Location NSW / QLD
Links https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=22171&isClinicalTrial=True
Trial Status Open
Trial Open Date 01/03/2024
Study Type Treatment
Phase Phase 2
Age Eligibility 0 - 21 years
ANZCTR NCT06208657

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.